Gales Ferry, CT, United States of America

Kevin W Kramer

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin W Kramer. Retrieved from https://idiyas.com/inventor/kevin-w-kramer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin W Kramer: Innovator in Anticancer Research

Introduction

Kevin W Kramer is a notable inventor based in Gales Ferry, Connecticut. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His work has been recognized through the granting of a patent, showcasing his innovative approach to combating cancer.

Latest Patents

Kevin holds a patent for "Biaryl compounds useful as anticancer agents." This patent highlights his commitment to advancing cancer treatment options and reflects his expertise in creating effective pharmaceutical compounds. He has been awarded 1 patent for his groundbreaking work.

Career Highlights

Kevin W Kramer is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other experts in the field and contribute to the development of new therapies. His career is marked by a dedication to improving patient outcomes through innovative research.

Collaborations

Throughout his career, Kevin has worked alongside talented colleagues, including Steven Wayne Goldstein and Kelly P Longo. These collaborations have fostered a dynamic research environment, enabling the exchange of ideas and the advancement of their collective goals.

Conclusion

Kevin W Kramer exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to anticancer research and his collaboration with esteemed colleagues underscore his commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…